bioAffinity Technologies, Inc. (BIAF) vs Eocene Ltd. (EOCN)

A side-by-side comparison of bioAffinity Technologies, Inc. and Eocene Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BIAF

bioAffinity Technologies, Inc.

$2M

$5.94HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT

EOCN

Eocene Ltd.

$4M

$3.38HealthcareDelayed quote: Oct 6, 2026, 10:41 AM EDT

Total return — BIAF vs EOCN

growth of $100 · dividends reinvested · last 1y

BIAF +2.7% (+2.7%/yr)EOCN -15.9% (-15.9%/yr)BIAF compounded faster over this window

BIAF EOCN

Metrics side by side

Total return (annualized)

Metric	BIAF	EOCN
Total return (1Y)	-84.05%	N/A
Total return CAGR (3Y)	-78.31%	N/A

EOCN is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full BIAF analysis Full EOCN analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.